Galectin-9 Induces Apoptosis in OVCAR-3 Ovarian Cancer Cell Through Mitochondrial Pathway

Overview

Journal Res Pharm Sci

Specialty Chemistry

Date 2019 Jan 5

PMID 30607153

Citations 14

Authors

Seyyed Mehdi Jafari

Ali Nazri

Mahdi Shabani

Narges Zargar Balajam

Mahmoud Aghaei

Affiliations

Soon will be listed here.

Abstract

Galectin-9 (Gal-9), a member of animal lectins' family, is implicated in the induction of apoptosis in various cancer cells. Here, we evaluated the anti-tumor effect of Gal-9 in OVCAR-3 ovarian cancer cells. The effect of the Gal-9 on cell viability was evaluated using MTT assays. Apoptosis was assessed using Annexin-V staining. The assessment of mitochondrial membrane potential (ΔΨm) was performed using a JC-1 probe. The activity of caspase-3 and caspase-6 were evaluated with colorimetric assay. The production of reactive oxygen species (ROS) was applied by fluorescent probe. The expression levels of Bax and Bcl-2 were assessed using western blotting. The result showed that Gal-9 inhibits cell viability. Flow cytometry analysis showed that Gal-9 induces apoptosis in ovarian cancer cells. Moreover, Gal-9 decreased ΔΨm and increased the generation of ROS and caspase-3 and caspase-6 activities in ovarian cancer cells. Moreover, Gal-9 induced expression of Bax as well as inhibited expression of Bcl-2. In conclusion, our results indicated that Gal-9 induced apoptosis in ovarian cancer cells through mitochondrial pathway.

Citing Articles

α2β1 Integrin specific inhibitor BTT-3033 promotes paclitaxel-induced apoptosis in human ovarian cancer cells.

Babaei Z, Amani M, Minaiyan M, Ghorbanhosseini S, Aghaei M Res Pharm Sci. 2024; 19(5):549-560.

PMID: 39691300 PMC: 11648348. DOI: 10.4103/RPS.RPS_245_23.

The effects of chitosan-loaded JQ1 nanoparticles on OVCAR-3 cell cycle and apoptosis-related gene expression.

Masoudi E, Soleimani M, Zarinfard G, Homayoun M, Bakhtiari M Res Pharm Sci. 2024; 19(1):53-63.

PMID: 39006975 PMC: 11244706. DOI: 10.4103/1735-5362.394820.

Expression of Intracellular Galectin-8 and -9 in Endometrial Cancer.

Beyer S, Wehrmann M, Meister S, Trillsch F, Ganster F, Schmoeckel E Int J Mol Sci. 2024; 25(13).

PMID: 39000016 PMC: 11241125. DOI: 10.3390/ijms25136907.

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance.

Choukrani G, Visser N, Ustyanovska Avtenyuk N, Olthuis M, Marsman G, Ammatuna E Cell Death Discov. 2023; 9(1):228.

PMID: 37407572 PMC: 10322858. DOI: 10.1038/s41420-023-01515-w.

Galectin functions in cancer-associated inflammation and thrombosis.

Kruk L, Braun A, Cosset E, Gudermann T, Mammadova-Bach E Front Cardiovasc Med. 2023; 10:1052959.

PMID: 36873388 PMC: 9981828. DOI: 10.3389/fcvm.2023.1052959.

References

Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J . Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo. Int J Oncol. 2015; 46(6):2419-30. DOI: 10.3892/ijo.2015.2941. View

Yamauchi A, Kontani K, Kihara M, Nishi N, Yokomise H, Hirashima M . Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer. Breast J. 2006; 12(5 Suppl 2):S196-200. DOI: 10.1111/j.1075-122X.2006.00334.x. View

Chaurio R, Janko C, Munoz L, Frey B, Herrmann M, Gaipl U . Phospholipids: key players in apoptosis and immune regulation. Molecules. 2009; 14(12):4892-914. PMC: 6255253. DOI: 10.3390/molecules14124892. View

Jiang J, Jin M, Kong F, Cao D, Ma H, Jia Z . Decreased galectin-9 and increased Tim-3 expression are related to poor prognosis in gastric cancer. PLoS One. 2013; 8(12):e81799. PMC: 3858245. DOI: 10.1371/journal.pone.0081799. View

Bowtell D, Bohm S, Ahmed A, Aspuria P, Bast Jr R, Beral V . Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer. Nat Rev Cancer. 2015; 15(11):668-79. PMC: 4892184. DOI: 10.1038/nrc4019. View

Fisher D . Apoptosis in cancer therapy: crossing the threshold. Cell. 1994; 78(4):539-42. DOI: 10.1016/0092-8674(94)90518-5. View

Wiersma V, de Bruyn M, Helfrich W, Bremer E . Therapeutic potential of Galectin-9 in human disease. Med Res Rev. 2011; 33 Suppl 1:E102-26. DOI: 10.1002/med.20249. View

Aghaei M, Karami-Tehrani F, Panjehpour M, Salami S, Fallahian F . Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3. Prostate. 2011; 72(4):361-75. DOI: 10.1002/pros.21438. View

Shahali A, Ghanadian M, Jafari S, Aghaei M . Mitochondrial and caspase pathways are involved in the induction of apoptosis by nardosinen in MCF-7 breast cancer cell line. Res Pharm Sci. 2018; 13(1):12-21. PMC: 5772077. DOI: 10.4103/1735-5362.220963. View

10.

Ghobrial I, Witzig T, Adjei A . Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 2005; 55(3):178-94. DOI: 10.3322/canjclin.55.3.178. View

11.

Poupel F, Aghaei M, Movahedian A, Jafari S, Keyvanloo Shahrestanaki M . Dihydroartemisinin Induces Apoptosis in Human Bladder Cancer Cell Lines Through Reactive Oxygen Species, Mitochondrial Membrane Potential, and Cytochrome C Pathway. Int J Prev Med. 2017; 8:78. PMC: 5651661. DOI: 10.4103/ijpvm.IJPVM_258_17. View

12.

Vergote I, Marth C, Coleman R . Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications. Cancer Metastasis Rev. 2015; 34(1):41-52. DOI: 10.1007/s10555-014-9539-8. View

13.

Joshaghani H, Jafari S, Aghaei M, Panjehpour M, Abedi H . A3 adenosine receptor agonist induce G1 cell cycle arrest via Cyclin D and cyclin-dependent kinase 4 pathways in OVCAR-3 and Caov-4 cell lines. J Cancer Res Ther. 2017; 13(1):107-112. DOI: 10.4103/0973-1482.199381. View

14.

Nabatchian F, Moradi A, Aghaei M, Ghanadian M, Jafari S, Tabesh S . New 6(17)-epoxylathyrane diterpene: aellinane from Euphorbia aellenii induces apoptosis via mitochondrial pathway in ovarian cancer cell line. Toxicol Mech Methods. 2017; 27(8):622-630. DOI: 10.1080/15376516.2017.1347735. View

15.

Kobayashi T, Kuroda J, Ashihara E, Oomizu S, Terui Y, Taniyama A . Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways. Leukemia. 2010; 24(4):843-50. DOI: 10.1038/leu.2010.25. View

16.

Marchi S, Giorgi C, Suski J, Agnoletto C, Bononi A, Bonora M . Mitochondria-ros crosstalk in the control of cell death and aging. J Signal Transduct. 2011; 2012:329635. PMC: 3235816. DOI: 10.1155/2012/329635. View

17.

Molavian H, Goldman A, Phipps C, Kohandel M, Wouters B, Sengupta S . Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci Rep. 2016; 6:27439. PMC: 4899687. DOI: 10.1038/srep27439. View

18.

Tadokoro T, Fujihara S, Chiyo T, Oura K, Samukawa E, Yamana Y . Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study. Int J Oncol. 2017; 51(2):607-614. DOI: 10.3892/ijo.2017.4053. View

19.

Kageshita T, Kashio Y, Yamauchi A, Seki M, Abedin M, Nishi N . Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance. Int J Cancer. 2002; 99(6):809-16. DOI: 10.1002/ijc.10436. View

20.

Ly J, Grubb D, Lawen A . The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update. Apoptosis. 2003; 8(2):115-28. DOI: 10.1023/a:1022945107762. View